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INTRODUCTION
Spondyloarthropathy (SpA) was introduced to describe a
family of arthritides of unknown etiology with both periph-
eral and axial manifestations sharing clinical and radiologi-
cal features as well as genetic predisposing factors. SpA in-
cludes ankylosing spondylitis (AS), Reiter’ s syndrome and
reactive arthritis, psoriatic arthritis, arthritis related to in-
flammatory bowel diseases, as well as other forms that do
not meet the criteria for these categories, called undifferen-
tiated spondyloarthropathy (USpA). The clinical spectrum
of USpA is therefore wide, due to various combinations of
clinical and radiological manifestations of SpA, i.e, inflam-
matory spinal pain including sacroiliitis, peripheral arthri-
tis, enthesitis, dactylitis, history of diarrhea and urinary
tract infection, psoriasis, and uveitis, each of which may also
occur in isolation.
Few studies have been published on USpA and peripheral
arthritis of UspA, because it has been overlooked in most
studies due to inadequacy of the existing classification crite-
ria and misdiagnosis as rheumatoid arthritis. With the use
of the recently developed European Spondyloarthropathy
Study Group (ESSG) criteria (1), the clinical characteristics of
USpA may be better defined and may also lead to early recog-
nition of such patients in clinical practice. We retrospectively
stud ied patients with USpA, focusing on the characteristics
and prognosis of peripheral arthritis.
MATERIALS AND METHODS
Patients
Among a total of 839 patients with SpA who visited our
hospital from 1992 to 1999, 412 had ankylosing spondyli-
tis, 107 had USpA, 17 had psoriatic arthritis, and 10 had
reactive arthritis. There was no subject with inflammatory
bowel disease. Among these subgroups, a total of 107 pat-
ients with USpA were included in this study and analyzed.
The diagnosis of USpA was made on those who fulfilled
ESSG criteria (1).
Demographic data
Medical records were reviewed retrospectively and data
on age, sex, age at symptom onset, symptom duration, and
onset of inflammatory back pain were recorded for all pat-
ients. Age at symptom onset was defined as time at which
the first symptom, whether it was axial symptom, peripher-
al arthritis, or enthesitis, had been initially noticed by each
patient. Symptom duration was calculated by subtracting
the year at symptom onset from 1999.
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Undifferentiated Spondyloarthropathy in Korea
-Focusing on Peripheral Arthritis-
Undifferentiated spondyloarthropathy (USpA) includes the forms that do not meet
criteria for the established categories of spondyloarthropathy. The clinical spec-
trum of USpA is therefore wide and few studies have been published on USpA,
especially peripheral arthritis. A total of 107 patients fulfilling the European Spondy-
loarthropathy Study Group criteria for SpA were studied retrospectively by a chart
review and interview by a rheumatologist. Peripheral arthritis, excluding hip and
shoulder involvement, occurred in 97 of the 107 patients (91%). Joint involvement
tended to be monoarticular or pauciarticular, and most frequently developed in
peripheral joints including the knee and ankle. Among the 97 patients with periph-
eral arthritis, only 37 (35%) had a persistent arthritis. HLA-B27 was detected in
80 patients (78%). Peripheral arthritis was found in the lower extremities regard-
less of symmetry or asymmetry and tended to run a benign course with only a
few patients having persistent arthritis 
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Clinical data
Patients were asked about family history (first and second
degree relatives) of SpA. All data were recorded about the de-
tails of inflammatory back pain, peripheral arthritis, enthesitis,
uveitis, history of diarrhea, urinary tract infection, psoriasis,
alternative buttock pain, and dactylitis. The determination
of current or previous inflammatory back pain was made
based on symptoms persisting at least 3 months, improving
with exercise and worsening with rest. Peripheral arthritis
was defined as the presence of swelling and/or restricted range
of motion in at least one peripheral joint, and/or history of
previous swelling in at least one peripheral joint confirmed
at that time by a rheumatologist (not including hip or shoul-
der joints) (1). Enthesitis was defined as inflammation and/
or pain of peripheral entheses such as in calcaneal insertions
of the Achilles tendon and plantar fascia, tibial tuberosities,
and costosternal junction. Dactylitis was defined as diffuse
digit swelling extending beyond the margin of the joint cap-
sule (2). In peripheral arthritis study, absence of peripheral
arthritis and enthesitis was defined as no arthritis and enthe-
sitis for at least 2 months. We identified the characteristics
of Korean USpA and the differences in clinical manifesta-
tions according to the sex. Also, we carefully analyzed the
course of peripheral arthritis in USpA.
Laboratory data
HLA-B27 by microcytotoxicity and radiological investi-
gations (pelvic and lumbar spine radiographs and radiographs
of painful joints and chest) were obtained.
Statistical analysis
Statistical analysis was performed using the SPSS statisti-
cal package. Chi-square test, Fisher’ s exact test, and t-test
for independent values were used as appropriate. P-value of
<0.05 was regarded as significant. Mann-Whitney U test
was performed to identify the correlation between peripher-
al arthritis and disease duration.
RESULTS
Overall outcome
Among the 107 patients with USpA, the male to female
ratio was 58:49 (male 54%, female 46%). The mean age at
onset was 27.4±11.6 yr (range, 7-58 yr; male, 26.6±13.0;
female, 28.3±9.7) and disease duration was 6.3±5.6 yr
(range, 3 months-39 yr, male, 6.5±6.4; female, 6.2±4.7).
The demographic characteristics are presented in Table 1.
Initial symptom
The most common initial symptom was arthritis of the
knee in 30 patients (28%), ankle in 15 (14%), buttock and
axial symptom in 23 (21%), and enthesitis including heel
and plantar area in 22 (21%).
Articular manifestation
A history of peripheral arthritis excluding the hip and
shoulder involvement was recorded in 97 patients (91%) in
a total of 107 patients. Arthritis involved the knee in 77 of
107 patients (72%). Among the patients with a history of
arthritis, both knees were involved in 39 patients (39%),
both ankles in 26 (53%), both elbows in 6 (27%), and wrists
and hands in 5 (22%) and 4 (16%), respectively. The num-
ber of joints involved was one in 12 patients, two in 25
patients, more than 2 and less than 4 joints in 30 patients,
and more than 5 joints in 31 patients. The peripheral arthri-
tis was more common in female than in male (98% vs 85%,
p<0.05). But the pattern of joint involvement was not dif-
SpA: spondyloarthropathy.
Demographics Number (%)
Male/female 58/49 (54/46)
Age at onset of disease (yr) 27.4±11.6
Disease duration (yr) 6.3±5.6
Family history of SpA 12 (11)
Uveitis 14 (13)
Microscopic hematuria 9 (8)
Dactylitis 3 (2)
History of urinary tract infection 0
History of diarrhea 0
Psoriasis 0
HLA-B27 80/103 (78)
HLA B7 6/103 (6)
Sacroiliitis 22 (21)
Table 1. Demographic and clinical characteristics of the 107
patients
Manifestation Number (%)
Arthritis 97 (91)
Knee 77 (72)
Ankle 49 (46)
Elbow 6 (27)
Wrist 23 (21)
Hand 25 (23)
Enthesitis 88 (82)
Heel pain 80 (75)
Plantar fascitis 42 (39)
Tibial tubercle 30 (28)
Chest pain 20 (19)
Inflammatory back pain 58 (54)
Table 2. Articular manifestations of Undifferentiated spondy-
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ferent between the two groups. The arthroscopic synovecto-
my of the knee was done in 8 patients. The 88 patients (82%)
had enthesitis. The Achilles tendinitis was found in 80
(75%). The 58 (54%) patients complained of inflammatory
back pain, 28 patients in hip (26%) and 15 patients in shoul-
der (14%). Sacroiliitis was diagnosed by pelvis radiography
in 22 patients (21%). The arthritic characteristics are sum-
marized in Table 2.
Extraarticular manifestations and laboratory findings
Uveitis developed in 14 patients (13%). Microscopic hema-
turia was found in 9 patients (8%), and biopsy was done in
6 patients thereof, all of whom were diagnosed with IgA
nephropathy. Dactylitis developed in 3 patients (2%) and a
family history of SpA was found in 12 (11%). No patient
suffered from urinary tract infection, diarrhea, or psoriasis.
HLA-B27 was done in 103 patients and 80 patients (78%)
were positive for HLA-B27. 
Combination of diagnostic criteria in USpA
The most common combined profile of USpA criteria was
peripheral arthritis and enthesitis (48%, respectively). Peri-
pheral arthritis, inflammatory back pain, and enthesitis were
observed in 39 patients (36%). Both inflammatory back pain
and enthesitis were observed in seven patients. Ten patients
had one minor criterion and one of two major factors.
Comparisons between the sexes
It was found that peripheral arthritis was the only feature
significantly more frequent in women than in men (98% and
85%, respectively; p<0.05). The disease duration did not
affect the course of peripheral arthritis. 
Prognosis of articular manifestation
Sulfasalazine (SSZ) was prescribed in 55 patients, a com-
bination of SSZ and methotrexate (MTX) in 35, and three
disease- modifying antirheumatic drugs (DMARDs) includ-
ing either SSZ or MTX in 7 patients. Ten patients did not
receive any DMARDs treatment. Among 97 patients with
peripheral arthritis, the arthritis subsided in 60 patients and
only 37 (35%) had a continuous peripheral arthritis at fol-
low-up. 
Although a history of peripheral arthritis was more fre-
quent in female patients, the difference in persistent arthri-
tis by sex was not statistically significant between two sexes
in the long run. Among 88 patients with enthesitis, only
32 (30%) had a persistent enthesitis. The persistence of the
peripheral arthritis and enthesitis had no relation with the
use of DMARDs.
DISCUSSION
The SpA is a group of inflammatory arthritic conditions
that share certain clinical and laboratory features. The main
clinical feature is an inflammatory back pain, which mani-
fests with stiffness in the buttocks and back. Peripheral arthri-
tis may be associated with spondylitis; it is characterized by an
absence of rheumatoid factor, hence is designated as seronega-
tive SpA. The arthritic involvement tends to be asymmet-
ric, most commonly in the lower extremities (3).
There have been studies on clinical features of the SpA (2-
9). The frequency of USpA is high and the 1:1 male: female
ratio has also been observed. The clinical spectrum of USpA
is as wide in the elderly as it is in children and young-middle
aged adults. However, late onset SpA is uncommon after 55
yr (10) and the pitting edema of the extremities, similar to
that of remitting seronegative symmetric synovitis with
pitting edema and to that of polymyalgia rheumatica, may
be observed (11). Our data shows the similar sex ratio and
the disease was not found in patients over 55 yr.
Because few studies have been published on peripheral
arthritis in USpA, we have focused on clinical characteristics
of USpA and peripheral arthritis in a series of 107 patients.
Peripheral arthritis occurred in 91% of our patients. The
percentage of peripheral arthritis was similar to those report-
ed in studies conducted by Boyer et al. (8), Mau et al. (9),
Prakash et al. (12) and Uppal et al. (13) (range, 52-100%).
According to Uppal et al. (13), USpA is frequent in females,
tends to involve fewer joints, and there is a greater tendency
towards asymmetry in females. Our study has provided an
opportunity to evaluate the characteristics of patients with
peripheral arthritis that have not been well defined in previ-
ous studies. Peripheral arthritis was more frequent in female
patients and was not associated with a longer disease dura-
tion. Joint involvement tended to be monoarticular or pau-
ciarticular, and regardless of symmetry or asymmetry, the
knee and ankle were most frequently involved. The periph-
eral arthritis was frequent, but not severe.
In India, Prakash et al. (12) reported that in 25 patients
attending to a rheumatology clinic with asymmetric seroneg-
ative arthritis mainly of the large joints of the lower limbs,
associated abnormalities were low back pain (52%), heel pain
(28%), sacroiliitis (16%) and mouth ulcer (8%). The patients
in this study presented a frequency of lower back pain (54%)
similar to that in the study by Boyer et al. However, the fre-
quencies of heel pain and sacroiliitis were higher than those
in the study by Boyer et al., showing 82% and 22%, respec-
tively.
Certain extra-articular features are common in USpA,
including skin and mucous membrane lesions, bowel com-
plaints, eye involvement, and aortic root dilatation. Boyer et
al. (8) reported numerous extra-articular manifestations in
24 Yupik Eskimo patients with USpA; enthesopathy in 56%,
mucocutaneous lesion in 16%, genitourinary features like74 T.-H. Kim, H.-S. Lee, J.-D. Ji, et al.
urethritis, epididymitis, prostatitis, and sterile pyuria in
28%, inflammatory bowel disease in 4%, conjunctivitis or
iritis in 33%, cardiac abnormalities (conduction disturbance,
pericarditis, and aortic regurgitation) in 8%. In our study,
these features were also present: enthesopathy in 82% and
uveitis in 13%. However, aortic regurgitation, history of
genitourinary features, inflammatory bowel disease, and pso-
riasis were not found.
Another feature common to SpA is the familial aggrega-
tion, which occurs within each condition and among enti-
ties within the group. An association with HLA-B27 has
been documented in the diseases (14-16). The frequency of
HLA-B27 may vary between populations, as shown by two
recent studies that reported HLA-B27 positivity in 56% of
patients with USpA in an Alaskan Eskimo population and
only 6% positivity in a population from Lebanon (17, 18).
In Linssen and Feltkamp (19), HLA-B27 positive patients
were shown to have an earlier onset of disease, a more severe
clinical course, increased frequency of acute anterior uveitis,
peripheral arthritis, and increased involvement of the axial
skeleton. Frankenberger et al. (20) reported a significantly
lower B2702 frequency in patients with USpA (6.7%) than
in those with AS (23.7%). In our analysis, HLA-B27 posi-
tivity was higher (78%), but no difference in the prevalence
of peripheral joint involvement was found between the HLA-
B27 positive and the HLA-B27 negative groups.
Clinical findings of the Korean patients with USpA are
similar to those of other countries. Peripheral arthritis is a
dominant manifestation and tends to run a benign course
with only a few patients having persistent arthritis.
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